Can You Use HSA or FSA for GLP-1 Weight Loss Medications?

Using HSA and FSA for GLP-1 Medications

If you have a Health Savings Account (HSA) or Flexible Spending Account (FSA), you may be able to use these pre-tax funds to pay for GLP-1 weight loss medications like semaglutide and tirzepatide. Since these are prescribed medications for a legitimate medical condition, they generally qualify as eligible expenses. Here is what you need to know about using your tax-advantaged healthcare funds for weight loss treatment.

HSA and FSA Eligibility for GLP-1 Medications

GLP-1 medications prescribed by a licensed healthcare provider for the treatment of obesity or overweight with comorbidities are generally considered eligible HSA and FSA expenses. This applies to both brand-name medications like Wegovy and Zepbound as well as compounded semaglutide and tirzepatide, provided they are prescribed by a licensed provider. The key requirement is that the medication must be prescribed for a medical condition, not for cosmetic purposes. Since obesity is classified as a chronic disease by the American Medical Association and virtually all major medical organizations, GLP-1 prescriptions for weight management typically meet this standard.

How to Pay with HSA or FSA

The process for using HSA or FSA funds is generally straightforward. Most telehealth providers accept HSA and FSA debit cards at checkout, just like a regular credit or debit card. If your provider does not accept the card directly, you can typically pay with a personal card and submit a claim for reimbursement to your HSA or FSA administrator. Keep your prescription documentation and receipts, as your plan administrator may request them for verification. Some HSA and FSA plans require a Letter of Medical Necessity from your provider, though this is less common for prescribed medications.

Using HSA or FSA funds effectively reduces your cost by your marginal tax rate. For someone in the 24% federal tax bracket, this means a $200 per month medication effectively costs $152 after the tax savings, potentially saving over $500 per year.

Does Insurance Cover GLP-1 Medications?

Insurance coverage for GLP-1 weight loss medications varies widely by plan. Some key distinctions to understand: brand-name Wegovy and Zepbound may be covered by commercial insurance plans, but many plans exclude weight loss medications or impose significant restrictions. Medicare Part D generally does not cover medications prescribed solely for weight loss, though recent legislative proposals may change this. Medicaid coverage varies by state. Compounded semaglutide and tirzepatide are typically not covered by insurance, as most plans only cover FDA-approved products dispensed from retail pharmacies.

Prior Authorization Requirements

Even when insurance does cover GLP-1 medications, most plans require prior authorization before they will approve the prescription. This process typically involves your provider documenting that you meet BMI criteria (30+ or 27+ with comorbidities), that you have attempted lifestyle modifications such as diet and exercise, that you do not have contraindications to the medication, and in some cases that you have tried and failed other weight loss treatments. The prior authorization process can take anywhere from a few days to several weeks. Your prescribing provider or the telehealth platform typically handles this process on your behalf, though delays are common.

If Insurance Denies Coverage

If your insurance denies coverage for a GLP-1 medication, you have several options. You can file a formal appeal with your insurance company, which sometimes succeeds especially if your provider submits additional medical justification. You can ask your provider about alternative medications that may be covered under your plan. You can switch to a compounded version through a telehealth provider, which is paid out of pocket but often costs less than the brand-name copay would have been. Or you can use your HSA or FSA to pay for the self-pay option, which helps offset the cost with pre-tax dollars.

Cost Comparison: Insurance vs Self-Pay

In many cases, self-pay compounded semaglutide is actually less expensive than brand-name medication through insurance. Consider this comparison: brand-name Wegovy with insurance may have a copay of $150 to $500 per month depending on your plan, assuming the prior authorization is approved. Without insurance, Wegovy costs $1,300 or more per month. Compounded semaglutide through a telehealth provider typically costs $149 to $399 per month with no prior authorization needed. When you factor in the time spent on prior authorization, the risk of denial, and the potential copay amount, many patients find that self-pay compounded options are both simpler and more affordable.